Oligio and Volnewmer Share a Predicate. Their Filings Don't Match From There.
Wontech’s Oligio and Classys’s Volnewmer both run 6.78MHz monopolar radiofrequency, and both cite the same predicate device in their US 510(k) filings. Line the two clearance packages up side by side, though, and the power ceiling, the cooling method, the tip lineup, the indications language, and even the category of testing submitted all read differently. Strip away the marketing copy and compare only what’s actually written in the regulatory filings and the manufacturers’ own spec sheets, and it becomes fairly clear where these two devices share a physical basis — and where the paper trail diverges.
Same predicate, different clearance language
Both Oligio (K221989) and Volnewmer (K240248) are classified under 21 CFR 878.4400 as electrosurgical cutting and coagulation devices, product code GEI, Class II. Both filings name Solta Medical’s Thermage FLX (K170758) as their predicate device; Volnewmer’s filing additionally lists Virtue RF (K211562) as a reference device.
The indications for use are not identical. Oligio is cleared for electrocoagulation and hemostasis of soft tissue in dermatologic and general surgery procedures. Volnewmer is cleared for the same tissue effect, but only within dermatologic procedures. What each filing actually certifies is substantial equivalence within that scope of use — neither document speaks to which device produces better cosmetic outcomes for skin laxity or wrinkles. Separately, Volnewmer’s product page references both FDA clearance and Korean MFDS approval together, but that pairing in marketing material doesn’t let you infer one country’s clearance from the other’s.
What the wattage says, and what it doesn’t
The recorded maximum output is 145W for Oligio and 115W for Volnewmer. Both fall under the 400W ceiling of their shared predicate, Thermage FLX, and Oligio’s summary addresses that gap directly: since the proposed device’s maximum stays within the predicate’s established output range, the difference doesn’t affect the safety or effectiveness equivalence determination. In other words, the 30W gap between the two was treated in review as a design choice within an accepted range, not as evidence one outperforms the other.
Both devices are described as delivering energy through the tip using a tuning approach that adjusts RF output across an impedance range. Volnewmer is the one with public numbers: its spec sheet lists an impedance response range of 75–400Ω, power consumption of 1200VA, two handpieces, and a 10.1-inch touchscreen. What’s missing from both documents is pulse duration and target tissue temperature or hold time — without those, wattage alone isn’t enough to calculate actual heat accumulated in tissue.
Cooling and tip specs are documented at very different depths
Volnewmer’s review table identifies its cooling mechanism as a water-cooled system, distinguishing it from its predicate Thermage FLX, which uses R-134A cryogen gas cooling. According to manufacturer materials, Volnewmer checks impedance once the tip makes contact, activates cooling, delivers a single pulse, and maintains continuous contact cooling to protect the epidermis throughout the procedure. The same materials describe a “hidden edge” electrode — set back inside the tip structure with the leading edge slightly raised so it doesn’t itself contact skin — curved and angled tip heads, and a 56kg console that includes the coolant.
Oligio’s documentation sits at a different level of detail. Its summary describes conductive cooling of the epidermis while selectively coagulating tissue, and its components list includes cooling gas — but it doesn’t specify the refrigerant type or the spray-timing sequence. What Oligio’s performance testing does record is handpiece vibration across three levels: low (30dB), medium (40dB), high (50dB). Tip area is another asymmetry: Volnewmer lists four sizes — 0.25 cm², 3.0 cm², 4.0 cm², and 16.0 cm² — while Oligio’s summary contains no area breakdown at all. That gap means these filings alone don’t support a side-by-side comparison of tip lineups.
The evidence submitted isn’t the same category
The type of validation data submitted diverges too. Oligio’s filing includes electrical safety and EMC testing, software verification, biocompatibility testing, and performance testing, and states plainly that a clinical trial was not deemed necessary and was not performed. Its software documentation level is listed as Basic.
Volnewmer’s filing adds thermal-effect and safety bench testing to electrical safety, EMC, and biocompatibility/bench testing, presenting that data as its equivalence evidence; its software documentation level is listed as Enhanced. That difference likely reflects different submission strategies and different points in time rather than a verdict on clinical superiority — and neither filing contains a direct comparative trial against the other device.
What’s left to compare from public material, then, isn’t a performance ranking — it’s operating conditions. A cooling-gas system that’s managed as a consumable and a water-circulation system that isn’t have different implications for inventory, maintenance, and installation space, and which tip sizes are actually available for a given treatment area shapes how a procedure gets planned. Anyone trying to genuinely compare these two devices would get further by requesting each country’s original clearance record, per-tip area and delivery parameters, and tissue temperature data measured under identical conditions — not by comparing wattage figures.
Entities covered in this article
Sources checked
Scope — This article explains devices and technology. It does not provide individual diagnosis or treatment advice.